{{Rsnum
|rsid=339331
|Gene=RFX6
|Chromosome=6
|position=116888889
|Orientation=plus
|GMAF=0.3182
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=RFX6
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 14.2 | 44.2 | 41.6
| HCB | 12.4 | 45.3 | 42.3
| JPT | 10.6 | 53.1 | 36.3
| YRI | 5.5 | 24.7 | 69.9
| ASW | 3.5 | 36.8 | 59.6
| CHB | 12.4 | 45.3 | 42.3
| CHD | 11.0 | 43.1 | 45.9
| GIH | 16.8 | 46.5 | 36.6
| LWK | 11.9 | 42.2 | 45.9
| MEX | 3.4 | 55.2 | 41.4
| MKK | 5.8 | 27.6 | 66.7
| TSI | 6.9 | 38.2 | 54.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20676098
|Trait=None
|Title=Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
|RiskAllele=T
|Pval=2E-12
|OR=1.22
|ORtxt=[1.15-1.28]
}}

{{PMID Auto
|PMID=22056501
|Title=Replication of five prostate cancer loci identified in an Asian population - Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
|OA=1
}}

{{PMID Auto
|PMID=22114074
|Title=Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
|OA=1
}}

{{PMID Auto
|PMID=22662242
|Title=Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population
|OA=1
}}

{{PMID Auto
|PMID=23405784
|Title=[Susceptibility to prostate cancer in Han Chinese: single nucleotide polymorphism analysis of 1 667 cases]
}}

{{PMID Auto
|PMID=24390282
|Title=A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
}}

{{PMID Auto
|PMID=23620269
|Title=Genetic variants in 2q31 and 5p15 are associated with aggressive benign prostatic hyperplasia in a Chinese population.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}